AzTrials
AzTrials

Intubation; Difficult or FailedNCT06115694

Comparison of Video Laryngoscopy With Rigid Stylet vs Video Laryngoscopy With the TCI Articulating Introducer for Endotracheal Intubation in Simulated Difficult Airways

A study testing TCI Articulating Introducer and GlideRite® Rigid Stylet in people with Intubation; Difficult or Failed, run by Tianjin Medical University General Hospital.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Purpose: To compare the efficacy and safety of TCI tube core and ordinary tube core assisted tracheal intubation in simulating difficult airway under visual laryngoscope, and to provide reference for clinical application Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Intubation; Difficult or Failed
What is being tested?
TCI Articulating Introducer and GlideRite® Rigid Stylet
Type of treatment
Medical device
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
240 participants
Where
No sites listed yet
Study dates
1 Nov 2023to 1 Jul 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Men ≥18 years of age or non-pregnant women;
  • For elective gynecological surgery or upper abdominal surgery under general anesthesia by oral tracheal intubation, the operation position was supine and the operation time was less than 3 hours;
  • Subject's American Society of Anesthesiologists physical status is I-III
  • Subjects who could understand the purpose of the trial, voluntarily participated and signed the informed consent form, and were willing to accept the designated follow-up.

Who cannot join

  • any cerebrovascular accident, such as stroke, transient ischemic attack (TIA), etc. occurred within 3 months;
  • patients with unstable angina pectoris or myocardial infarction within 3 months;
  • laryngeal mass, obstruction, maxillofacial fracture or deformity;
  • Full stomach, high intra-abdominal pressure, habitual vomiting, gastroesophageal reflux disease;
  • pharyngeal infection, hematoma, abscess, tonsil enlargement;
  • Upper respiratory tract infection within one month, fever, cough, runny nose, nasal congestion, etc.;
Show all 13Show fewer
  • history of chronic airway inflammation, airway hyperresponsiveness or asthma;
  • diabetic patients with severe diabetic complications (diabetic ketoacidosis, hyperosmolar coma, various infections, macroangiopathy, diabetic nephropathy, retinopathy, diabetic cardiomyopathy, diabetic neuropathy, diabetic foot, etc.);
  • severe complications of hypertension, such as arterial dissection, renal failure, cerebral hemorrhage, etc.;
  • reoperation within 3 months;
  • patients with contraindications or allergies to intraoperative drugs;
  • patients enrolled in other studies within 30 days;
  • poor adherence or the investigator's opinion that the patient was not suitable for the study.

Trial locations and contacts

No sites are listed yet.

About this study

Official title: Comparison of Video Laryngoscopy With Rigid Stylet vs Video Laryngoscopy With the TCI Articulating Introducer for Endotracheal Intubation in Simulated Difficult Airways:A Prospective Randomized Controlled Multicenter Study

Purpose:

To compare the efficacy and safety of TCI tube core and ordinary tube core assisted tracheal intubation in simulating difficult airway under visual laryngoscope, and to provide reference for clinical application

Read the detailed description

Endotracheal intubation plays an important role in contemporary clinical anesthesia. Direct laryngoscope intubation is the traditional intubation method in anesthesia and emergency medical work. However, due to the constraints of the operator's technical level, the abnormal airway structure and the condition of patients, about 1.5% ~ 8.5% of the cases of intubation difficulties occur. It's even impossible to intubate. Failure of intubation can lead to major complications, including brain damage and death. When a tracheal intubation cannot be placed on the first two attempts, the intubation is classified as difficult, and repeated routine tracheal intubation may lead to morbidity in the patient, and the incidence of airway related complications increases significantly with the number of tracheal intubations. Difficult intubation accounted for 4% of operating room intubation and 10% of intubation outside the operating room. For patients with high glottis and short epiglottis, although the glottis can be seen, intubation is difficult to place. The effectiveness and safety of TCI tube assisted intubation under visual laryngoscope and ordinary tube tube assisted intubation in simulated difficult airway were compared to provide reference for clinical application.

Being tested
TCI Articulating Introducer, GlideRite® Rigid Stylet
Keywords
TCI Articulating Introducer, Endotracheal cannula, Simulated difficult airway

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • TCI Articulating IntroducerDevice

    use

  • GlideRite® Rigid StyletDevice

    use

Study groups in NCT06115694
Study groupRoleWhat they receive
Experimental group:TCI Articulating IntroducerActive comparatorTracheal intubation was performed using a TCI core under a visual laryngoscope
Receives: Device: TCI Articulating Introducer
Control group:GlideRite® Rigid StyletPlacebo comparatorTracheal intubation was performed under a visual laryngoscope using a common tube core
Receives: Device: GlideRite® Rigid Stylet

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The success of intubation for the first time

    To compare the success rate of first intubation in simulated difficult airway with TCI tube assisted by visual laryngoscope and ordinary tube.

    Measured: 1 day of surgery

Secondary outcomes (3)
  1. Overall success rate of intubation

    Overall success rate of tracheal intubation assisted by TCI and conventional tube cores under video laryngoscope in all included patients

    Measured: 1 day of surgery

  2. Whether it is necessary to rotate the tracheal tube through the glottis

    Whether it is necessary to rotate during tracheal intubation to successfully enter the airway through the glottis

    Measured: 1 day of surgery

  3. Throat complications

    Whether the following conditions will occur after operation: oral mucosal injury: tracheal tube stained with blood or secretion with blood when extubation; Sore throat: patients complained of throat discomfort, manifested as slurred speech, foreign body sensation, cough, etc. Loose teeth; Difficulty speaking; Patients were followed up for 24 hours after surgery to see whether they still had dysphagia, nausea, vomiting, and cough.

    Measured: 24 hours after surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Nov 2023
  2. Study start1 Nov 2023 (estimated)
  3. Primary completion1 Nov 2023 (estimated)
  4. Study completion1 Jul 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
240 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06115694
Sponsor's protocol ID
GWang025
Status last verified
Oct 2023
First submitted
30 Oct 2023
Last updated
3 Nov 2023
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing TCI Articulating Introducer and GlideRite® Rigid Stylet in people with Intubation; Difficult or Failed, run by Tianjin Medical University General Hospital.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 13 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 3 Nov 2023. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Wei Cui,MD (13821678013, cuwe2528@sina.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The success of intubation for the first time (time frame: 1 day of surgery). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Nov 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in